Silica in oral drugs as a possible sarcoidosis-inducing antigen

The Lancet

Volumn 373, Issue 9679, 2009, Pages 1943-1944

  Solà, Rosa ^a   Boj, Montserrat ^a   Hernandez Flix, Salvador ^a   Camprubí, Mercé ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; DOXAZOSIN; LOSARTAN; SILICON DIOXIDE; VALSARTAN;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG FORMULATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; HYPERTENSION; LETTER; LIFESTYLE MODIFICATION; MALE; PRIORITY JOURNAL; SARCOIDOSIS;

EID: 66549111661     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61057-6     Document Type: Letter

References (5)

1. Iannuzzi M.C., Rycicki B.A., and Teirstein A.S. Medical progress: sarcoidosis. N Engl J Med 357 (2007) 2153-2165
2. Newman L.S., Rose C.S., Bresnitz E.A., et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170 (2004) 1324-1330
3. Kucera G.P., Rybicki B.A., Kirkey K.L., et al. Occupational risk factors for sarcoidosis in African-American siblings. Chest 123 (2003) 1527-1535
4. Rafnsson V., Ingimarsson O., Hjalmarsson I., and Gunnarsdottir H. Association between exposure to crystalline silica and risk of sarcoidosis. Occup Environ Med 55 (1998) 657-660
5. Rybicki B.A., and Iannuzzi M.C. Epidemiology of sarcoidosis: recent advances and future prospects. Semin Respir Crit Care Med 28 (2007) 22-35